针对八种抗生素的Helicobacter pylori的抗生素敏感性模式:北印度的一项研究
Safiya Arfi1, Prateek Sharma1, Mithun Kumar2
1Centre for Medical Biotechnology, Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India.
Helicobacter
|May 17, 2024
概括
这项研究揭示了北印度的Helicobacter pylori (H. pylori) 菌株的高耐药性,而勒沃素显示出显著的耐药性. 环素,阿莫西西林,澄素和利法布丁在对抗H. pylori感染方面仍然更有效.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 杆菌 (H. pylori) 感染是一个重大的全球健康问题.
- 了解抗微生物敏感性和遗传多样性对于有效的治疗策略至关重要.
研究的目的:
- 评估八种药物对H.pylori菌株的抗微生物敏感性.
- 评估北印度H. pylori病毒性基因的遗传多样性.
- 将这些因素与潜在的临床结果相关联.
主要方法:
- 分析了来自胃肠道疾病患者的58种H. pylori菌株.
- 抗生素最小抑制度 (MIC) 通过阿加稀释法确定.
- 统计分析包括千平方和费舍尔精确测试;RStudio用于数据可视化.
主要成果:
- 对于勒沃素 (70.7%),美特罗尼达 (39.6%),塞菲西 (41.3%) 和法拉佐利 (34.4%) 观察到高耐药率.
- 多种药物耐药性在27.3%的菌株中普遍存在.
- 对美特罗尼达,克拉利胺和利法布丁的耐药性在女性中显著更高.
结论:
- 环素,阿莫西西林,明素和利法布丁显示出对H. pylori的更高疗效.
- 需要进一步的研究,以解决日益增长的抗药性水平的levofloxacin.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
371
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
371
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
113
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
113
Antibiotic Selection
53.2K
Overview
53.2K
Peptic Ulcer Disease I: Introduction
164
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
164


